Document:

Registration Rights Agreement Dated as of Nov. 5, 2004

 Exhibit 4.2 
 EXECUTION COPY 
  

 REGISTRATION RIGHTS AGREEMENT 
 by and among 
 Monotype Imaging Holdings Corp., 
 the Investors, 
 and 
 the Management Stockholders 
 Dated as of November 5, 2004 
  

 TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
	1.	  	Certain Definitions	  	1
			
	2.	  	Demand Registrations	  	2
			
	3.	  	Form S-3	  	4
			
	4.	  	Piggyback Registration	  	4
			
	5.	  	Registration Procedures	  	5
			
	6.	  	Expenses	  	8
			
	7.	  	Indemnification	  	8
			
	8.	  	Compliance with Rule 144	  	10
			
	9.	  	Amendments	  	11
			
	10.	  	Transferability of Registration Rights	  	11
			
	11.	  	Rights That May Be Granted to Subsequent Investors	  	11
			
	12.	  	Damages	  	11
			
	13.	  	Miscellaneous	  	11
			
	14.	  	Dispute Resolution	  	13

  

 i 

 REGISTRATION RIGHTS AGREEMENT 
 This REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is dated as of November 5, 2004, by and among Monotype Imaging
Holdings Corp., a Delaware corporation (the “Company”), the persons designated as Investors on the signature pages hereto (the “Investors”) and the persons who become parties to this Agreement as Management
Stockholders (the “Management Stockholders”) as contemplated herein. 
 WHEREAS, the Management Stockholders are
officers and employees of Monotype Imaging, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company; 
 WHEREAS, the
board of directors of the Company (the “Board of Directors”) and the Investors have authorized the Company to provide the Management Stockholders with the opportunity to purchase shares of Convertible Preferred Stock and Common
Stock (as such terms are defined herein) under conditions that make the purchases exempt from the registration requirements of the Securities Act (as defined below) pursuant to Regulation D or Rule 701 thereunder; and 
 WHEREAS, shortly following the execution of this Agreement, the Management Stockholders shall purchase shares of Convertible Preferred Stock and
Common Stock and, by entering into an investment and joinder agreement with the Company, become parties to this Agreement, which sets forth the rights and obligations with respect to the registration of securities of the Company held by the
Investors and the Management Stockholders. 
 NOW, THEREFORE, in consideration of the premises and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby covenant and agree with each other as follows: 
 1. Certain Definitions. As used in this Agreement, the following terms shall have the following meanings: 
 “Charter” shall mean the Company’s Amended and Restated Articles of Incorporation in effect as of the date hereof, as amended from time to time. 
 “Commission” shall mean the United States Securities and Exchange Commission. 
 “Common Stock” shall mean the common Stock, par value $0.01 per share, of the Company (as more fully described in the Charter), and any
other common equity securities issued by the Company, together with any shares issued or issuable with respect thereto (whether by way of a stock dividend or stock split or in exchange for or in replacement of such shares or otherwise in connection
with a combination of shares, recapitalization, merger, consolidation or other corporate reorganization). 
 “Convertible Preferred
Stock” shall mean the Convertible Preferred Stock, par value $0.01 per share, of the Company (as more fully described in the Charter), together with any shares issued or issuable with respect thereto (whether by way of a stock dividend or
stock split or in exchange for or in replacement of such shares or otherwise in connection with a combination of shares, recapitalization, merger, consolidation or other corporate reorganization). 

 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules
and regulations thereunder. 
 “Person” shall mean an individual, a corporation, a joint venture, a trust, an unincorporated
organization, a limited liability company or partnership, a government and any agency or political subdivision thereof. 
 “Registrable Securities” shall mean (i) any shares of Common Stock held by the Investors or Management Stockholders, or subject to acquisition by any Investor or Management Stockholder upon conversion of Convertible
Preferred Stock (it being understood that for purposes of this Agreement, an Investor or Management Stockholder will be deemed to be a holder of Registrable Securities whenever such Investor has the right to then acquire or obtain from the Company
any Registrable Securities, whether or not such acquisition has actually been effected), and (ii) any other securities issued and issuable with respect to any such shares described in clause (i) above by way of a stock dividend or stock
split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization; provided, however, that if an Investor or Management Stockholder owns Convertible Preferred Stock, the Investor or
Management Stockholder may exercise its registration rights hereunder by converting the shares of Convertible Preferred Stock into the shares of Common Stock to be sold under the relevant registration statement as of the closing of the relevant
offering and shall not be required to cause such Convertible Preferred Stock to be converted to Common Stock unless and until such closing occurs, it being understood that the Company shall at the request of the relevant Investor or Management
Stockholder effect the reconversion of Common Stock acquired upon conversion of Convertible Preferred Stock to Convertible Preferred Stock if such a conversion occurs, notwithstanding the foregoing, and the relevant offering does not close; and
provided, further, that any shares of Common Stock that are sold in a registered sale pursuant to an effective registration statement under the Securities Act or pursuant to Rule 144 thereunder, or that may be sold (as confirmed by an
unqualified opinion of counsel to the Company) without restriction as to volume or otherwise pursuant to Rule 144(k) under the Securities Act shall not be deemed Registrable Securities. 
 “Registration Expenses” shall mean the expenses so described in Section 6 hereof. 
 “Securities Act” shall mean the Securities Act of 1933, as amended and the rules and regulations thereunder. 
 “Two-Thirds Interest” shall mean Investors holding not less than two-thirds in number of the outstanding Registrable Securities held by
all Investors. 
 2. Demand Registrations. 
 (a) At any time after the initial public offering of the Company’ Common Stock pursuant to an effective registration statement under the Securities Act (the “IPO”), a Two-Thirds Interest may
request that the Company register under the Securities Act the sale of all or any portion of the Registrable Securities held by such Two-Thirds Interest; provided that 

  

 2 

 
any registration statement related to such sale may not become effective prior to the six (6) month anniversary of the effectiveness of the IPO. Upon
receipt of such request, the Company shall promptly deliver notice of such request to all other holders of Registrable Securities, if any, who shall then have thirty (30) days to notify the Company in writing of their desire to be included in
such registration. The Company shall state in the written notice whether the request for registration contemplates an underwritten public offering, and, in such event, the right of any holder of Registrable Securities to participate in such
registration shall be conditioned upon their participation in such underwritten public offering and the inclusion of their Registrable Securities in the underwritten public offering on the terms for such offering as may be summarized in such notice,
which terms will be no less favorable than the terms applicable to the Two-Thirds Interest. The Company will use its best efforts to expeditiously effect the registration of the sale of all Registrable Securities whose holders request participation
in such registration under the Securities Act and to qualify such Registrable Securities for sale under the securities laws of any State; provided, however, that the Company shall not be required to effect a registration pursuant to a request
under this Section 2 more than three (3) times. Notwithstanding anything to the contrary contained herein, no request may be made under this Section 2 within ninety (90) days after the effective date of a registration
statement filed by the Company covering a firm commitment underwritten public offering. The Company may postpone the filing or the effectiveness of any registration statement pursuant to this Section 2 for a reasonable time period if
(i) the Company has been advised by legal counsel that such filing or effectiveness would require disclosure of material non-public information, and the Board of Directors determines in good faith that such disclosure would be detrimental to
the Company and its stockholders, or (ii) the Board of Directors determines in good faith that there is a valid business purpose or reason for delaying filing or effectiveness; provided that in no such case may such periods of
postponement exceed an aggregate of ninety (90) days in any period of twelve (12) consecutive months. A registration will not count as a requested registration under this Section 2(a) until the registration statement relating to such
registration has been declared effective by the Commission. Without limiting the generality of the foregoing, if a Two-Thirds Interest shall request in writing that the Company withdraw a registration statement that has been filed under this
Section 2(a) but not yet been declared effective, such request shall not count as a requested registration under this Section 2(a), unless such Two-Thirds Interest thereafter requests the Company to reinstate such registration statement,
if permitted under the Securities Act, or to file another registration statement, in accordance with the procedures set forth herein. 
 (b)
If a registration requested under Section 2(a) involves an underwritten public offering and the managing underwriter of such offering determines in good faith that the registration of all or part the securities requested to be included in such
offering would have a material and adverse effect on the success of such offering, then the number of securities to be included in such offering shall be reduced to a number deemed satisfactory by such managing underwriter. In such case, the shares
to be excluded from such offering shall be determined in the following order: (i) first, securities held by any Persons not having registration rights with respect to securities of the Company, (ii) second, securities held by any Persons
other than any of the parties to this Agreement having contractual, incidental “piggy back” registration rights to include such securities in the registration statement pursuant to an agreement other than this Agreement, (iii) third,
securities sought to be registered by the Company for its own account and (iv) fourth, holders of Registrable Securities, it being understood that no securities shall be registered for the account of the Company or any other Person other than
the holders of 

  

 3 

 
Registrable Securities unless all Registrable Securities for which holders thereof have requested registration have been registered. If there is a reduction
of the number of securities to be included in such offering and described in any of clauses (i), (ii) or (iv), such reduction shall be made on a pro rata basis (based upon the aggregate number of securities held by the holders in each such
category and subject to the priorities set forth in the preceding sentence). 
 (c) With respect to a request for registration pursuant to
Section 2(a) that is for an underwritten public offering, the managing underwriter shall be chosen by Investors holding not less than two-thirds of the Registrable Securities to be sold in such offering, subject to the Company’ consent,
which such consent shall not be unreasonably withheld. The Company may not cause any other registration of securities for sale for its own account (other than a registration effected solely to implement an employee benefit plan or a transaction to
which Rule 145 of the Securities Act is applicable) to become effective within one hundred eighty (180) days following the date any registration statement filed under this Section 2 has been declared effective by the Commission.

 3. Form S-3. Following the IPO, the Company shall use its best efforts to qualify and remain qualified to register
securities on Form S-3 under the Securities Act. For so long as the Company is qualified to register securities on Form S-3, Investors holding Registrable Securities anticipated to have an aggregate sale price (net of underwriting discounts and
commissions, if any) in excess of $500,000 shall have the right, on one or more occasions, to request registration on Form S-3 of the sale of the Registrable Securities held by such requesting Investors. Such requests shall be in writing and shall
state the number of shares of Registrable Securities to be disposed of and the intended method of disposition of such shares by such Investors. The Company shall give notice to all other Investors and the Management Stockholders holding Registrable
Securities of the receipt of a request for registration pursuant to this Section 3 and such Investors and Management Stockholders shall then have thirty (30) days to notify the Company in writing of their desire to participate in the
registration. The Company shall use its best efforts to effect promptly the registration of all shares on Form S-3 to the extent requested by such Investors and Management Stockholders; provided, however, that the Company may postpone the
filing or the effectiveness of any registration statement pursuant to this Section 3 for a reasonable period of time if (i) the Company has been advised by legal counsel that such filing or effectiveness would require disclosure of
material non-public information, and the Board of Directors determines in good faith that such disclosure would be detrimental to the Company and its stockholders, or (ii) the Board of Directors determines in good faith that there is a valid
business purpose or reason for delaying filing or effectiveness; provided that in no such case may such periods of postponement exceed an aggregate of ninety (90) days in any period of twelve (12) consecutive months. 
 4. Piggyback Registration. If the Company shall propose to register the sale to the public of any of its Common Stock or securities
convertible into or exchangeable or exercisable for any of its Common Stock under the Securities Act (other than (i) pursuant to a demand under Section 2 or Section 3 of this Agreement, in which case the rights of holders of
Registrable Securities to participate therein shall be as set forth therein (ii) with respect to registration statements on Forms S-4 or S-8 or (iii) in connection with a registration effected solely to implement an employee benefit plan
or a transaction to which Rule 145 or any other similar rule of the Commission under the Securities Act is applicable), the Company shall promptly give 
  

 4 

 
written notice at the applicable address of record to each holder of Registrable Securities of such proposed registration. Upon the written request of any of
such holder, given within thirty (30) days after receipt by such holder of such notice, the Company shall, subject to the limits contained in this Section 4, use its best efforts to cause all such Registrable Securities of said requesting
holder to be registered under the Securities Act and qualified for sale under the securities laws of any State, all to the extent required to permit such sale or other disposition of said Registrable Securities. Notwithstanding the foregoing, in any
public offering of securities of the Company, if any managing underwriter determines in good faith that the registration of all or part of the securities requested to be included in such registration by Persons other than the Company (collectively,
“Selling Stockholders”) would have a material and adverse effect on the success of such offering, the Company may reduce the amount offered for the accounts of Selling Stockholders (including Selling Stockholders holding Registrable
Securities) to a number deemed satisfactory by such managing underwriter. In such event, the shares to be excluded shall be determined in the following order: (A) first, securities held by any Persons not having registration rights with respect
to securities of the Company, (B) second, securities held by any Persons other than any of the parties to this Agreement having contractual, incidental “piggyback” registration rights to include such securities in the registration
statement and (C) third, the Registrable Securities sought to be included by the holders thereof requesting registration. If there is a reduction of the number of securities to be included in such offer and described in any of clauses (A),
(B) or (C), such reduction shall be made on a pro rata basis (based upon the aggregate number of securities held by the holders in each such category and subject to the priorities set forth in the preceding sentence). 
 5. Registration Procedures. If and whenever the Company is required by the provisions of this Agreement to effect the registration of any
of its securities under the Securities Act, the Company will, as expeditiously as possible: 
 (a) prepare and file with the Commission a
registration statement on the appropriate form under the Securities Act with respect to such securities, which registration statement shall comply with the requirements of such form and include all financial statements required by the Commission to
be filed therewith, and use its best efforts to cause such registration statement to become and remain effective until completion of the proposed offering; 
 (b) prepare and file with the Commission such amendments, post-effective amendments, and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such
registration statement effective as contemplated herein and to comply with the provisions of the Securities Act with respect to the sale or other disposition of all securities covered by such registration statement whenever the seller or sellers of
such securities shall desire to sell or otherwise dispose of the same, but only to the extent provided in this Agreement; 
 (c) furnish to
each selling holder and the underwriters, if any, such number of copies of such registration statement, any amendments thereto, any documents incorporated by reference therein, the prospectus, including a preliminary prospectus, in conformity with
the requirements of the Securities Act, and such other documents as such selling holder may reasonably request in order to facilitate the public sale or other disposition of the securities owned by such selling holder; 
  

 5 

 (d) register or qualify the securities covered by such registration statement under the securities or
“blue sky” laws of such jurisdictions as each selling holder may request, and do any and all other acts and things that may be necessary under such securities or “blue sky” laws to enable such selling holder to consummate the
public sale or other disposition in such jurisdictions of the securities owned by such selling holder; provided that the Company shall not be required to register or qualify the securities in any jurisdictions in which doing so would require
the Company to qualify to do business or subject itself to general service of process therein; 
 (e) within a reasonable time before each
filing of the registration statement or prospectus or amendments or supplements thereto with the Commission, furnish to counsel selected by the holders of Registrable Securities copies of such documents proposed to be filed, which documents shall be
subject to the approval of such counsel; 
 (f) immediately notify each selling holder of Registrable Securities, such selling holders’
counsel and any underwriter and (if requested by any such Person) confirm such notice in writing, of the happening of any event that makes any statement made in the registration statement or related prospectus untrue, or that requires the
making of any changes in such registration statement or prospectus so that they will not contain any untrue statement of a material fact, or omit to state any material fact required to be stated therein or necessary to make the statements therein
not misleading; and thereafter, prepare and file with the Commission and furnish a supplement or amendment to such prospectus so that, as thereafter deliverable to the purchasers of such Registrable Securities, such prospectus will not contain any
untrue statement of a material fact or omit to state a material fact necessary to make the statements therein not misleading; 
 (g) use its
best efforts to prevent the issuance of any order suspending the effectiveness of a registration statement, and if one is issued immediately notify each selling holder of Registrable Securities of the receipt of such notice and use its reasonable
best efforts to obtain the withdrawal of any order suspending the effectiveness of a registration statement at the earliest possible moment; 
 (h) if requested by the managing underwriter or underwriters (if any), any selling holder, or such selling holder’s counsel, promptly incorporate in a prospectus supplement or post-effective amendment such information as such Person
requests to be included therein with respect to the selling holder or the securities being sold, including, without limitation, with respect to the securities being sold by such selling holder to such underwriter or underwriters, the purchase price
being paid therefor by such underwriter or underwriters and with respect to any other terms of an underwritten offering of the securities to be sold in such offering, and promptly make all required filings of such prospectus supplement or
post-effective amendment; 
 (i) make available to each selling holder, any underwriter participating in any disposition pursuant to a
registration statement, and any attorney, accountant or other agent or representative retained by any such selling holder or underwriter (collectively, the “Inspectors”), all financial and other records, pertinent corporate
documents and properties of the Company (collectively, the “Records”), as shall be reasonably necessary to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors and employees to

  

 6 

 
supply all information requested by any such Inspector in connection with such registration statement subject, in each case, to such confidentiality
agreements as the Company shall reasonably request; 
 (j) enter into any reasonable underwriting agreement required by the proposed managing
underwriter or underwriters for the selling holders, if any, and use its best efforts to facilitate the public offering of the securities; provided, however, that no selling holder shall be required to make any representations or warranties
other than with respect to its title to the Registrable Securities and any written information provided by it to the Company specifically for use in the registration statement, and if the proposed managing underwriter or underwriters require that
representations or warranties be made and that indemnification or, where indemnification is not available, contribution be provided, the Company shall make all such representations and warranties and provide all such indemnities, including, without
limitation, in respect of the Company’s business, operations and financial information and the disclosures relating thereto in the prospectus; 
 (k) request that each prospective selling holder be furnished a signed counterpart, addressed to the prospective selling holder, of (i) an opinion of counsel for the Company, dated the effective date of the registration statement, and
(ii) if and to the extent permitted by applicable professional standards, a “comfort” letter signed by the independent public accountants who have certified the Company’ financial statements included in the registration
statement, covering substantially the same matters with respect to the registration statement (and the prospectus included therein) and (in the case of the accountants’ letter) with respect to events subsequent to the date of the financial
statements, as are customarily covered (at the time of such registration) in opinions of the Company’ counsel and in accountants’ letters delivered to the underwriters in underwritten public offerings of securities; 
 (l) cause the securities covered by such registration statement to be listed on the securities exchange or quoted on the quotation system on which the
similar securities issued by the Company are then listed or quoted (or, if the Common Stock is not yet listed or quoted, then on such exchange or quotation system as the selling holders of Registrable Securities and the Company shall determine);

 (m) otherwise use its best efforts to comply with all applicable rules and regulations of the Commission and make generally available to
its stockholders, in each case as soon as practicable, but not later than 30 days after the close of the period covered thereby, an earnings statement of the Company that will satisfy the provisions of Section 11(a) of the Securities Act and
Rule 158 thereunder (or any comparable successor provisions); 
 (n) from and after the date of the Company’ initial public offering,
comply with all applicable requirements of the Sarbanes-Oxley Act and all applicable listing requirements, and in connection therewith establish and maintain a system of adequate internal financial controls and a Board of Directors comprised of a
majority of independent directors which directors shall comprise the audit committee and be members of the compensation and nominating and governance committees; 
  

 7 

 (o) during the period when the prospectus is required to be delivered under the Securities Act, promptly
file all documents required to be filed with the Commission pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act; 
 (p)
appoint a transfer agent and registrar for all Registrable Securities covered by a registration statement not later than the effective date of such registration statement; 
 (q) in connection with an underwritten offering, to the extent reasonably requested by the managing underwriter for the offering or the selling holders,
participate in and support customary efforts to sell the securities in the offering, including, without limitation, participating in “road shows”; and 
 (r) otherwise cooperate with any underwriters, the Commission and other regulatory agencies and take all reasonable actions and execute and deliver or cause to be executed and delivered all documents reasonably
necessary to effect the registration of any securities under this Agreement. 
 6. Expenses. All expenses incurred by the
Company and the holders of Registrable Securities being registered in a registration provided for in Sections 2, 3 and 4, including, without limitation, all registration and filing fees, printing expenses, reasonable fees and disbursements of
counsel for the Company and one counsel (but not more than one counsel) for the holders of Registrable Securities participating in such registration as a group (selected the Investors holding a majority of the Registrable Securities being sold in
the registration), underwriting expenses (other than underwriting commissions and discounts relating to the sale and registration of Registrable Securities), expenses of any audits incident to or required by any such registration and expenses of
complying with the securities or blue sky laws of any jurisdictions (all of such expenses referred to as “Registration Expenses”), shall be paid by the Company. 
 7. Indemnification. 
 (a)
Incident to any registration statement referred to in this Agreement, and subject to applicable law, the Company shall indemnify and hold harmless each underwriter (but in no event to any greater extent than any such underwriter may be entitled
under any applicable underwriting or indemnification and contribution agreement between the Company and such underwriter) each holder of Registrable Securities (including its partners (including partners of partners and stockholders of any such
partners), and directors, officers, employees and agents of any of them, and each person who controls any of them within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (a “Controlling
Person”) who offers or sells any such Registrable Securities in connection with such registration statement, from and against any and all losses, claims, expenses, damages or liabilities, joint or several (including any investigation, legal
and other expenses incurred in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted), as the same are incurred to which they, or any of them, may become subject under the Securities Act, the
Exchange Act, other federal or state statutory law or regulation, at common law, or otherwise (collectively, “Losses”), insofar as such Losses arise out of or are based upon (i) any untrue statement or alleged untrue statement
of any material fact contained, on the effective date thereof, in any 
  

 8 

 
registration statement under which such securities were registered under the Securities Act (including any preliminary prospectus or final prospectus
contained therein, or any amendment or supplement thereto), (ii) any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or (iii) any
violation by the Company of the Securities Act, any state securities or “blue sky” laws or any rule or regulation thereunder in connection with such registration. Except as otherwise provided in Section 7(d), the Company shall
reimburse each such indemnified party in connection with investigating or defending any Losses as expenses in connection with the same are incurred. The Company shall not be liable to any indemnified party, however, in any such case to the extent
that any such Losses arise out of or are based upon any untrue statement or alleged untrue statement or omission or alleged omission made in such registration statement, preliminary or final prospectus, or amendment or supplement thereto in reliance
upon and in conformity with information furnished in writing to the Company by or on behalf of such indemnified party specifically for use therein, and the Company shall not be required to indemnify any indemnified party against any Losses arising
from any untrue or misleading statement or omission contained in any preliminary prospectus if such deficiency is corrected in the final prospectus or for any liability which arises out of the failure of any indemnified party to deliver a prospectus
as required by the Securities Act. 
 (b) Each holder selling Registrable Securities included in such registration being effected shall
indemnify and hold harmless each underwriter (but in no event to any greater extent than any such underwriter may be entitled under any applicable underwriting or indemnification and contribution agreement between the Company and such underwriter),
the Company (including its directors, officers, employees and agents), and each other selling holder (including its partners (including partners of partners and stockholders of such partners) and directors, officers, employees and agents of any of
them), and any Person that is a Controlling Person with respect to any of them, from and against any and all Losses to the same extent provided in Section 7(a) above, insofar as such Losses arise out of or are based upon (i) any untrue
statement or alleged untrue statement of any material fact contained, on the effective date thereof, in any registration statement under which securities were registered under the Securities Act at the request of such selling holder, any preliminary
prospectus or final prospectus contained therein, or any amendment or supplement thereto or (ii) any omission or alleged omission by such selling holder to state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, in the case of both (i) and (ii) to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in such registration statement,
preliminary or final prospectus, amendment or supplement thereto in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of such selling holder specifically for use therein. In no event, however, shall
the liability of any selling holder for indemnification under this Section 7 in its capacity as a seller of Registrable Securities exceed the lesser of (A) a proportion of the total amount of such Losses that is equal to the proportion
that the number of securities sold under such registration statement by such selling holder bears to the total number of all such securities sold or (B) the amount equal to the proceeds to such selling holder of the securities sold in any such
registration. Further, no selling holder shall be required to indemnify any Person against any Losses arising from any untrue or misleading statement or omission contained in any preliminary prospectus if such deficiency is corrected in the final
prospectus or for any liability which arises out of the failure of any Person to deliver a prospectus as required by the Securities Act. 
  

 9 

 (c) If the indemnification provided for in this Section 7 for any reason is held by a court of
competent jurisdiction to be unavailable to an indemnified party in respect of any Losses then each indemnifying party under this Section 7, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or
payable by such indemnified party as a result of such Losses (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, the selling holders and the underwriters from the offering of the Registrable
Securities or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative
fault of the Company, the selling holders and the underwriters in connection with the statements or omissions that resulted in such Losses, as well as any other relevant equitable considerations. The relative benefits received by the Company, the
selling holders and the underwriters shall be deemed to be in the same respective proportions that the net proceeds from the offering (before deducting expenses) received by the Company and the selling holders, and the underwriting discount received
by the underwriters, in each case as set forth in the table on the cover page of the applicable prospectus, bear to the aggregate public offering price of the Registrable Securities. The relative fault of the Company, the selling holders and the
underwriters shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company, the
selling holders or the underwriters and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 
 The Company and the selling holders agree that it would not be just and equitable if contribution pursuant to this Section 7 were determined by pro
rata or per capita allocation or by any other method of allocation that does not take account of the equitable considerations referred to in the immediately preceding paragraph. In no event, however, shall a selling holder be required to contribute
any amount under this Section 7(c) in excess of the lesser of (A) a proportion of the total of such losses, claims, damages, expenses or liabilities indemnified against equal to the percentage of the total Registrable Securities sold under
such registration statement that are being sold by such selling holder, or (B) the net proceeds received by such selling holder from its sale of Registrable Securities under such registration statement. No Person found guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not found guilty of such fraudulent misrepresentation. 
 (d) The indemnification and contribution provided for in this Section 7 will remain in full force and effect regardless of any investigation made by
or on behalf of the indemnified parties or any officer, director, employee, agent or controlling person of the indemnified parties. 
 8.
Compliance with Rule 144. In the event that the Company (i) registers a class of securities under Section 12 of the Exchange Act, or (ii) shall commence to file reports under Section 13 or 15(d) of the Exchange Act,
the Company will use its best efforts (A) thereafter to timely file with the Commission such information and reports as are required under the 
  

 10 

 
Exchange Act for so long as there are holders of Registrable Securities and (B) to take all action as may be required as a condition to the availability
to the holders of Registrable Securities of Rule 144 or Rule 144A under the Securities Act. The Company shall furnish to any holder of Registrable Securities upon request a written statement executed by the Company as to the steps it has taken
to comply with the current public information requirement of Rule 144 or Rule 144A (or such comparable successor rules). 
 9.
Amendments. The provisions of this Agreement may be amended with the written consent of the Company, a Two-Thirds Interest and Management Stockholders holding a majority of the outstanding Registrable Securities then held by all
Management Stockholders. 
 10. Transferability of Registration Rights. The rights of the Investors and the Management
Stockholders that are set forth in this Agreement are transferable and assignable to any permitted transferee of Registrable Securities; provided that each transferee of Registrable Securities must consent in writing to be bound by the terms
and conditions of this Agreement in order to acquire the rights granted pursuant to this Agreement. 
 11. Rights That May Be Granted
to Subsequent Investors. Other than transferees as contemplated by Section 10, the Company shall not, without the prior written consent of a Two-Thirds Interest and Management Stockholders holding a majority of the outstanding
Registrable Securities then held by all Management Stockholders, (a) allow Persons that acquire any of the Company’s securities to become a party to this Agreement or (b) grant any registration or similar rights to any third parties
other than piggyback registration rights that are subordinate to the rights of holders of Registrable Securities under this Agreement. 
 12. Damages. The Company recognizes and agrees that each holder of Registrable Securities will not have an adequate remedy if the Company fails to comply with the terms and provisions of this Agreement and that damages will
not be readily ascertainable, and the Company expressly agrees that, in the event of such failure, it shall not oppose an application by any holder of Registrable Securities requiring specific performance of any and all provisions hereof or
enjoining the Company from continuing to commit any such breach of this Agreement. 
 13. Miscellaneous. 
 (a) All notices, requests, demands and other communications provided for hereunder shall be in writing and mailed (by first class registered or certified
mail, postage prepaid), telegraphed, sent by express overnight courier service or electronic facsimile transmission (with a copy by mail), or delivered to the applicable party at the addresses indicated below: 
 If to the Company: 
 Monotype Imaging
Holdings Corp. 
 200 Ballardvale Street 
 Wilmington, MA 01887 
 Attn:
                             
 Telecopy No.:
                             
  

 11 

 With a copy to: 
 TA Associates, Inc. 
 High Street Tower, Suite 2500 
 125 High Street 
 Boston, MA 02110 

Attn: A. Bruce Johnston 
         Jonathan W. Meeks 
 Telecopy No.: (617) 574-6728 
 If to the Investors: 
 TA Associates,
Inc. 
 High Street Tower, Suite 2500 
 125 High Street 
 Boston, MA 02110 
 Attn: A. Bruce Johnston 
         Jonathan W. Meeks 
 Telecopy No.: (617) 574-6728 
 With a
copy to: 
 D.B. Zwirn Special Opportunities Fund, L.P. 
 745 Fifth Avenue, 18th Floor 
 New York, NY 10151 
 Attn: Vasan Kesavan, Esq.

 Telecopy No.: (646) 746-8669 
 And: 
 Goodwin Procter LLP 
 Exchange Place 
 53 State Street 
 Boston, MA 02109 
 Attn: Jeffrey C. Hadden,
P.C. 
 Telecopy No.: (617) 523-1231 
 If to any other holder of Registrable Securities: 
 At such holder’s address for notice as then
set forth in the books and records of the Company; 
 or, as to each of the foregoing, at such other address as shall be designated by such Person in a
written notice to other parties complying as to delivery with the terms of this subsection (a). All such notices, requests, demands and other communications shall, when mailed, telegraphed or sent, respectively, be effective (i) two days after
being deposited in the mails or (ii) one day after being delivered to the telegraph company, deposited with the express overnight courier service or sent by electronic facsimile transmission, respectively, addressed as aforesaid. 
  

 12 

 (b) This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of
Massachusetts, without giving effect to conflict of laws principles thereof. 
 (c) This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 (d) If
any provision of this Agreement shall be held to be illegal, invalid or unenforceable, such illegality, invalidity or unenforceability shall attach only to such provision and shall not in any manner affect or render illegal, invalid or unenforceable
any other provision of this Agreement, and this Agreement shall be carried out as if any such illegal, invalid or unenforceable provision were not contained herein. 
 14. Dispute Resolution. 
 (a) All disputes, claims, or controversies arising out of or relating
to this Agreement, or any other agreement executed and delivered pursuant to this Agreement, or the negotiation, validity or performance hereof and thereof or the transactions contemplated hereby and thereby, that are not resolved by mutual
agreement shall be resolved solely and exclusively by binding arbitration to be conducted before J.A.M.S./Endispute, Inc. in Boston, Massachusetts before a single arbitrator (the “Arbitrator”). 
 (b) The parties covenant and agree that the arbitration shall commence within ninety (90) days of the date on which a written demand for arbitration
is filed by any party hereto. In connection with the arbitration proceeding, the arbitrator shall have the power to order the production of documents by each party and any third-party witnesses. In addition, each party may take up to three
depositions as of right, and the arbitrator may in his or her discretion allow additional depositions upon good cause shown by the moving party. However, the arbitrator shall not have the power to order the answering of interrogatories or the
response to requests for admission. In connection with any arbitration, each party shall provide to the other, no later than seven (7) business days before the date of the arbitration, the identity of all persons that may testify at the
arbitration, a copy of all documents that may be introduced at the arbitration or considered or used by a party’s witness or expert. The Arbitrator’s decision and award shall be made and delivered within six (6) months of the
selection of the Arbitrator. The Arbitrator’s decision shall set forth a reasoned basis for any award of damages or finding of liability. The Arbitrator shall not have power to award damages in excess of actual compensatory damages and shall
not multiply actual damages or award punitive damages or any other damages that are specifically excluded under this Agreement, and each party hereby irrevocably waives any claim to such damages. 
 (c) The parties covenant and agree that they will participate in the arbitration in good faith and that they will, except as provided below,
(i) bear their own attorney’s fees, costs and expenses in connection with the arbitration and (ii) share equally in the fees and 

  

 13 

 
expenses charged by the Arbitrator. The Arbitrator may in his or her discretion assess costs and expenses (including the reasonable legal fees and expenses
of the prevailing party) against any party to a proceeding. Any party unsuccessfully refusing to comply with an order of the Arbitrator’s shall be liable for costs and expenses, including attorneys’ fees, incurred by the other party in
enforcing the award. This Section 14 applies equally to requests for temporary, preliminary or permanent injunctive relief, except that in the case of temporary or preliminary injunctive relief any party may proceed in court without prior
arbitration for the limited purpose of avoiding immediate and irreparable harm or to enforce its rights under any non-competition covenants. 
 (d) Each of the parties hereto irrevocably and unconditionally consents to the exclusive jurisdiction of J.A.M.S./Endispute, Inc. to resolve all disputes, claims or controversies arising out of or relating to this Agreement or any other
agreement executed and delivered pursuant to this Agreement or the negotiation, validity or performance hereof and thereof or the transactions contemplated hereby and thereby and further consents to the jurisdiction of the courts of the Commonwealth
of Massachusetts for the purposes of enforcing the arbitration provisions of Section 14 of this Agreement. Each party further irrevocably waives any objection to proceeding before the Arbitrator based upon lack of personal jurisdiction or to
the laying of venue and further irrevocably and unconditionally waives and agrees not to make a claim in any court that arbitration before the Arbitrator has been brought in an inconvenient forum. Each of the parties hereto hereby consents to
service of process by registered mail at the address to which notices are to be given. Each of the parties hereto agrees that its or his submission to jurisdiction and its or his consent to service of process by mail is made for the express benefit
of the other parties hereto. 
 [Remainder of page intentionally left blank.] 
  

 14 

 IN WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly
executed as of the date first set forth above. 
  

			
	COMPANY:
	
	MONOTYPE IMAGING HOLDINGS CORP.
		
	By:	 	 /s/ A. BRUCE JOHNSTON

	Name:	 	A. Bruce Johnston
	Title:	 	Vice President

 Registration Rights Agreement 

					
	INVESTORS:
	
	TA IX L.P.
	By: TA Associates IX LLC, its General Partner
	By: TA Associates, Inc., its Manager
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA/ATLANTIC AND PACIFIC IV L.P.
	By: TA Associates AP IV L.P., its General Partner
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA STRATEGIC PARTNERS FUND A L.P.
	By: TA Associates SPF L.P., its General Partner
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA STRATEGIC PARTNERS FUND B L.P.
	By: TA Associates SPF L.P., its General Partner
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director

 Registration Rights Agreement 

					
	TA INVESTORS II, L.P.
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA SUBORDINATED DEBT FUND, L.P.
	By: TA Associates SDF LLC, its General Partner
	By: TA Associates, Inc., its Manager
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director

  

			
	*  By:	 	 /s/ A. BRUCE JOHNSTON

	    Name:	 	A. Bruce Johnston
	    Title:	 	Managing Director

  

					
	D.B. ZWIRN SPECIAL OPPORTUNITIES FUND, L.P.
	
	By: D.B. Zwirn Partners, LLC, its General Partner
	By: Zwirn Holdings, LLC, its Managing Member
			
		 	By:	 	 /s/ DANIEL B. ZWIRN

		 	Name:	 	
		 	Title:	 	

 Registration Rights AgreementStockholders Agreement Dated as of Nov. 5, 2004

 Exhibit 4.3 
 EXECUTION COPY 
 STOCKHOLDERS AGREEMENT 
 by and among 
 Monotype Imaging
Holdings Corp., 
 the Management Stockholders named herein 
 and 
 the Investors named herein 
 Dated as of November 5, 2004 

 TABLE OF CONTENTS 
  

							
	 	  	 	  	 	  	Page
	SECTION I. DEFINITIONS	  	2
		  	1.1.	  	Construction of Terms	  	2
		  	1.2.	  	Terms Not Defined	  	2
		  	1.3.	  	Number of Shares of Stock	  	2
		  	1.4.	  	Defined Terms	  	2
		
	SECTION II. REPRESENTATIONS AND WARRANTIES	  	4
		  	2.1.	  	Representations and Warranties of the Management Stockholders	  	4
		  	2.2.	  	Representations and Warranties of the Investors	  	4
		  	2.3.	  	Representations and Warranties of the Company	  	5
		
	SECTION III. RESTRICTIONS ON TRANSFER; RIGHT OF FIRST REFUSAL; CO-SALE PROVISIONS; DRAG ALONG	  	5
		  	3.1.	  	Restrictions on Transfer	  	5
		  	3.2.	  	Permitted Transfers	  	5
		  	3.3.	  	Right of Refusal	  	6
		  	3.4.	  	Co-Sale Option of Investors	  	8
		  	3.5.	  	Co-Sale Option of Management Stockholders	  	9
		  	3.6.	  	Drag Along	  	11
		  	3.7.	  	Contemporaneous Transfers	  	12
		  	3.8.	  	Effect of Prohibited Transfers	  	12
		  	3.9.	  	Assignment of Rights	  	12
		
	SECTION IV. RIGHTS TO PURCHASE	  	12
		  	4.1.	  	Right to Participate in Certain Sales of Additional Securities	  	12
		  	4.2.	  	Eligible Person Acceptance	  	13
		  	4.3.	  	Calculation of Pro Rata Allotment	  	13
		  	4.4.	  	Sale to Third Party	  	13
		  	4.5.	  	Exceptions to Pre-Emptive Rights	  	13
		  	4.6.	  	Assignment of Rights	  	14
		  	4.7.	  	Company Repurchase	  	14
		
	SECTION V. ELECTION OF DIRECTORS	  	14
		  	5.1.	  	Management Stockholder Board Representation	  	14
		  	5.2.	  	Removal; Vacancies	  	14
		
	SECTION VI. COVENANTS OF THE COMPANY AND MANAGEMENT STOCKHOLDERS	  	15
		  	6.1.	  	Financial Statements, Reports, Etc	  	15
		  	6.2.	  	Inspection, Consultation and Advice	  	16
		  	6.3.	  	Key Person Insurance	  	16

  

 i 

							
		  	6.4.	  	Directors and Officers’ Insurance; Charter and Bylaws	  	16
		  	6.5.	  	Reimbursement of Directors	  	17
		  	6.6.	  	Employee Agreements	  	17
		  	6.7.	  	Lock-Up Agreements	  	17
		  	6.8.	  	Material Adverse Change	  	17
		  	6.9.	  	Indemnification	  	17
		
	SECTION VII. MISCELLANEOUS PROVISIONS	  	19
		  	7.1.	  	Reliance	  	19
		  	7.2.	  	Legend on Securities	  	19
		  	7.3.	  	Amendment and Waiver; Actions of the Board	  	19
		  	7.4.	  	Notices	  	19
		  	7.5.	  	Headings	  	21
		  	7.6.	  	Counterparts	  	21
		  	7.7.	  	Remedies; Severability	  	21
		  	7.8.	  	Entire Agreement	  	21
		  	7.9.	  	Adjustments	  	22
		  	7.10.	  	Law Governing	  	22
		  	7.11.	  	Successors and Assigns	  	22
		  	7.12.	  	Dispute Resolution	  	22
		  	7.13.	  	Termination	  	23
		  	7.14.	  	Stockholder Lock-Up	  	23
		  	7.15.	  	Confidentiality	  	24

 EXHIBITS 
  

					
	Exhibit A	  	-	    	Form of Joinder Agreement
	Exhibit B	  	-	    	Form of Employee Noncompetition, Confidential Information and Inventions Assignment Agreement

 SCHEDULES 
  

					
	Schedule A	  	-	    	Investors

  

 ii 

 “Company” shall have the meaning set forth in the preamble to this Agreement and shall
include any successor thereto. 
 “Convertible Preferred Stock” shall mean the convertible preferred stock, par value $0.01
per share, of the Company (as more fully described in the Charter) and any other shares of stock issued or issuable with respect thereto (whether by way of a stock dividend or stock split or in exchange for, or upon conversion of, such shares or
otherwise in connection with a combination of shares, recapitalization, merger, consolidation or other corporate reorganization). 
 “Director” shall mean a member of the Board of Directors. 
 “Equity Incentive Plan” means the
Company’s 2004 Stock Option and Grant Plan, as amended from time to time. 
 “Exchange Act” shall mean the Securities
Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder. 
 “Material Adverse Effect”
means a material adverse effect on the assets, liabilities, condition (financial or other), business, results of operations or prospects of the Company. 
 “Permitted Transferee” shall have the meaning set forth in Section 3.2 of this Agreement. 
 “Person” shall mean any individual, corporation, joint venture, trust, unincorporated organization, limited liability company, partnership, government and any agency or political subdivision thereof. 
 “Preferred Stock” shall mean the Redeemable Preferred Stock and the Convertible Preferred Stock. 
 “Proceeding” shall mean any complaint, lawsuit or similar legal action filed in any court and any investigation, formal or informal, by
regulatory or self-regulatory authority or any other Person. 
 “Qualified Public Offering” shall have the meaning set forth
in the Charter. 
 “Redeemable Preferred Stock” shall mean the redeemable preferred stock, par value $0.01 per share, of the
Company, together with any shares issued or issuable with respect thereto (whether by way of a stock dividend or stock split or in exchange for, or upon conversion of, such shares or otherwise in connection with a combination of shares,
recapitalization, merger, consolidation or other corporate reorganization). 
 “Securities Act” shall mean the Securities
Act of 1933, as amended, and the rules and regulations of the Commission thereunder. 
 “Shares” shall mean, at any time,
(i) shares of Common Stock, (ii) shares of Preferred Stock and (iii) any other equity securities now or hereafter issued by the Company, together with 

  

 3 

 
any options thereon and any other shares of stock issued or issuable with respect thereto (whether by way of a stock dividend, stock split or in exchange
for, or upon conversion of, such shares or otherwise in connection with a combination of shares, recapitalization, merger, consolidation or other corporate reorganization); provided, however, that the term “Shares” shall not
comprise any shares of Common Stock or options to purchase Common Stock issued under the Equity Incentive Plan or any other securities of the Company or any Affiliate thereof issued or issuable with respect thereto. 
 “Transfer” means any direct or indirect transfer, donation, sale, assignment, pledge, hypothecation, grant of a security interest in or
other disposal or attempted disposal of, all or any portion of a security, any interest or rights in, a security, or any rights under this Agreement. “Transferred” means the accomplishment of a Transfer, and “Transferee” means
the recipient of a Transfer. 
 “Two-Thirds Interest” shall mean Investors holding not less than 66 2/3% of the outstanding
Shares held by all Investors, calculated in accordance with Section 1.3 hereof. 
 SECTION II. REPRESENTATIONS AND WARRANTIES 

2.1. Representations and Warranties of the Management Stockholders. Each of the Management Stockholders, individually and not jointly, hereby
represents, warrants and covenants to the Company and the Investors as follows: (a) such Management Stockholder has full authority, power and capacity to enter into this Agreement and perform its obligations hereunder; (b) this Agreement
constitutes the valid and binding obligation of such Management Stockholder enforceable against it in accordance with its terms; and (c) the execution, delivery and performance by such Management Stockholder of this Agreement (i) does not
and will not violate any laws, rules or regulations of the United States or any state or other jurisdiction applicable to such Management Stockholder, or require such Management Stockholder to obtain any approval, consent or waiver of, or to make
any filing with, any other Person that has not been obtained or made and (ii) does not and will not result in a breach of, constitute a default under, accelerate any obligation under or give rise to a right of termination of any indenture or
loan or credit agreement or any other material agreement, contract, instrument, mortgage, lien, lease, permit, authorization, order, writ, judgment, injunction, decree, determination or arbitration award to which such Management Stockholder is a
party or by which the property of such Management Stockholder is bound or affected, or result in the creation or imposition of any mortgage, pledge, lien, security interest or other charge or encumbrance on any of the assets or properties of such
Management Stockholder. 
 2.2. Representations and Warranties of the Investors . Each of the Investors, individually and not jointly,
hereby represents, warrants and covenants to the Company and the Management Stockholders as follows: (a) such Investor has full authority, power and capacity to enter into this Agreement and perform its obligations hereunder; (b) this
Agreement constitutes the valid and binding obligation of such Investor enforceable against it in accordance with its terms; and (c) the execution, delivery and performance by such Investor of this Agreement (i) does not and will not
violate any laws, rules or regulations of the United States or any state or 
  

 4 

 
other jurisdiction applicable to such Investor, or require such Investor to obtain any approval, consent or waiver of, or to make any filing with, any Person
that has not been obtained or made and (ii) does not and will not result in a breach of, constitute a default under, accelerate any obligation under or give rise to a right of termination of any indenture or loan or credit agreement or any
other material agreement, contract, instrument, mortgage, lien, lease, permit, authorization, order, writ, judgment, injunction, decree, determination or arbitration award to which such Investor is a party or by which the property of such Investor
is bound or affected, or result in the creation or imposition of any mortgage, pledge, lien, security interest or other charge or encumbrance on any of the assets or properties of such Investor. 
 2.3. Representations and Warranties of the Company. The Company hereby represents, warrants and covenants to the Investors and the Management
Stockholders as follows: (a) the Company has full authority, power and capacity to enter into this Agreement and perform its obligations hereunder; (b) this Agreement constitutes the valid and binding obligation of the Company enforceable
against it in accordance with its terms; and (c) the execution, delivery and performance by the Company of this Agreement (i) does not and will not violate any laws, rules or regulations of the United States or any state or other
jurisdiction applicable to the Company, or require the Company to obtain any approval, consent or waiver of, or to make any filing with, any Person that has not been obtained or made and (ii) does not and will not result in a breach of,
constitute a default under, accelerate any obligation under or give rise to a right of termination of any indenture or loan or credit agreement or any other material agreement, contract, instrument, mortgage, lien, lease, permit, authorization,
order, writ, judgment, injunction, decree, determination or arbitration award to which the Company is a party or by which the property of the Company is bound or affected, or result in the creation or imposition of any mortgage, pledge, lien,
security interest or other charge or encumbrance on any of the assets or properties of the Company. 
  

	SECTION	III. RESTRICTIONS ON TRANSFER; RIGHT OF FIRST REFUSAL; CO-SALE PROVISIONS; DRAG ALONG 

 3.1. Restrictions on Transfer. Each Management Stockholder and D.B. Zwirn agrees that such Management Stockholder or D.B. Zwirn, as
applicable, will not, without the prior written consent of a Two-Thirds Interest, Transfer all or any portion of the Shares now owned or hereafter acquired by such Management Stockholder or D.B. Zwirn, as applicable, except in connection with, and
strictly in compliance with, the provisions of this Section III. 
 3.2. Permitted Transfers. Notwithstanding anything herein
to the contrary, the provisions of Sections 3.3 and 3.4 shall not apply to Transfers of the type described below in subsections (a), (b), (c) or (d); provided that, in the case of any such Transfer, the Transferee shall have entered into
a Joinder Agreement in order for such Transfer to have become effective, providing that all Shares so Transferred shall continue to be subject to all provisions of this Agreement as if such Shares were still held by such Management Stockholder or
D.B. Zwirn, as applicable, except that no further Transfer shall thereafter be permitted hereunder except in compliance with Sections 3.3 and 3.4: 
  

 5 

 (a) Transfers by any Management Stockholder to (i) any of such Management Stockholder’s
children, stepchildren or grandchildren (or any of their spouses), parents, stepparents, grandparents, spouse, domestic partner, siblings, in-laws or persons related by reason of legal adoption (collectively, the “Family Members”),
(ii) any trust for the benefit of such Management Stockholder and/or such Family Members, (iii) any charitable trust or foundation the trustees of which include such Management Stockholder and/or Family Members and (iv) any limited
partnership or limited liability company the sole partners or members of which are such Management Stockholder and/or Family Members; 
 (b)
Transfers upon the death of any Management Stockholder to such Management Stockholder’s heirs, executors or administrators or to a trust under such Management Stockholder’s will, or Transfers between such Management Stockholder and such
Management Stockholder’s guardian or conservator; 
 (c) Transfers by any Management Stockholder to any other Management Stockholder as
long as such other Management Stockholder is an employee or director of the Company or one of its Subsidiaries at the time such Transfer is completed; and 
 (d) Transfers by D.B. Zwirn to any of its Affiliates and Transfers by any Affiliate of D.B. Zwirn to D.B. Zwirn or any other Affiliate of D.B. Zwirn. 
 Notwithstanding anything to the contrary in this Agreement, and without limiting the rights of the Company set forth in Section 3.8 of this Agreement, if a Transferee that is a party to a Transfer described in
this Section 3.2 fails to execute a Joinder Agreement, such Transferee shall take any Shares so Transferred subject to all provisions of this Agreement as if such Shares were still held by D.B. Zwirn or the Management Stockholder making such
Transfer, as applicable, and no further Transfer shall thereafter be permitted or recognized, whether or not they so agree in writing. 
 3.3. Right of Refusal. In the event that any of the Management Stockholders or D.B. Zwirn entertains a bona fide, arm’s length offer (a “Transaction Offer”) from any other Person (a
“Buyer”) to purchase for cash all or any portion of the Shares held by such Management Stockholder or D.B. Zwirn, as applicable, such Management Stockholder or D.B. Zwirn, as applicable (a “Transferring
Stockholder”), may, subject to the provisions of Section 3.4 hereof, Transfer such Shares pursuant to and in accordance with the following provisions of this Section 3.3: 
 (a) Offer Notice. The Transferring Stockholder shall cause the Transaction Offer and all of the terms thereof to be reduced to writing and shall
(i) promptly notify the Company and each of the Investors of such Transferring Stockholder’s desire to effect the Transaction Offer (such notice, the “Offer Notice”) and (ii) otherwise comply with the provisions of
this Section 3.3 and, if applicable, Section 3.4. The Offer Notice shall constitute an irrevocable offer to sell all, but not less than all, of the Shares that are the subject of the Transaction Offer (the “Offered
Shares”) to the Investors, on the basis described below, at a purchase price equal to the price contained in, and on the same terms and conditions as, the Transaction Offer. The Offer Notice shall be accompanied by a true copy of the
Transaction Offer (which shall identify the Buyer and all relevant information in connection therewith). 
  

 6 

 (b) Investors’ Option. At any time within thirty (30) days after receipt by the
Investors of the Offer Notice (the “Investor Option Period”), each Investor or any of its Affiliates, including future funds that have affiliated but not identical general partners, may elect to accept the offer of the Transferring
Stockholder to purchase a portion of the Offered Shares and shall give written notice of such election (the “Investor Acceptance Notice”) to the Transferring Stockholder and each other Investor within the Investor Option Period,
which notice shall indicate the maximum number of Offered Shares that the Investor is willing to purchase, including the number of Offered Shares it would purchase if one or more other Investors do not elect to purchase their Pro Rata Fractions (as
defined in paragraph (c) below); provided, however, that the Investors must collectively purchase all of the Offered Shares. An Investor Acceptance Notice shall constitute a valid, binding and enforceable agreement for the sale and
purchase of the Offered Shares covered by such Investor Acceptance Notice. The closing for the purchase of Offered Shares by the Investors or any of their Affiliates under this Section 3.3(b) shall take place within thirty (30) days
following the expiration of the Investor Option Period at the offices of the Company or on such other date or at such other place as may be agreed to by the Transferring Stockholder and such Investors or Affiliates. The Transferring Stockholder
shall notify the Investors promptly if any Investor or Affiliate fails to offer to purchase all of its Pro Rata Fraction. 
 (c)
Allocation of Offered Shares among Investors. Upon the expiration of the Investor Option Period, the number of Offered Shares to be purchased by each Investor or any of its Affiliates shall be determined as follows: (i) first, there
shall be allocated to each Investor electing to purchase a number of Offered Shares equal to the lesser of (A) the number of Offered Shares as to which such Investor accepted the offer to purchase, as set forth in its respective Investor
Acceptance Notice and (B) such Investor’s Pro Rata Fraction (as defined below), and (ii) second, the balance, if any, not allocated under clause (i) above, shall be allocated to those Investors that, within the Investor Option
Period, delivered an Investor Acceptance Notice that accepted the offer to purchase with respect to a number of Offered Shares that exceeded their respective Pro Rata Fractions, in each case on a pro rata basis in proportion to the number of
Shares held by each such Investor up to the amount of such excess. As used herein, an Investor’s “Pro Rata Fraction” shall be equal to the product obtained by multiplying (x) the total number of Offered Shares by
(y) a fraction, the numerator of which is the total number of Shares owned by such Investor, and the denominator of which is the total number of Shares held by all Investors, in each case calculated as of the date of the Offer
Notice. 
 (d) Sale to Third Party. If the Investors do not elect to exercise the rights to purchase under this Section 3.3 with
respect to all of the Offered Shares, the Transferring Stockholder may sell such Shares to the Buyer on the terms and conditions set forth in the Offer Notice, subject to the provisions of Section 3.4. If the Transferring Stockholder’s
sale to a Buyer is not consummated in accordance with the terms of Section 3.4, the Transaction Offer shall be deemed to lapse, and any Transfers of Shares arising out of or resulting from such Transaction Offer shall be in violation of the
provisions of this Agreement unless the Transferring Stockholder sends a new Offer Notice and once again complies with the provisions of this Section 3.3 with respect to such Transaction Offer. 
  

 7 

 3.4. Co-Sale Option of Investors. If a Transferring Stockholder provides an Offer Notice to
sell Offered Shares and the Investors do not elect to exercise the rights to purchase under Section 3.3 with respect to all of the Offered Shares, the Transferring Stockholder may sell such Offered Shares to the Buyer on the terms and
conditions set forth in the Offer Notice, subject to the provisions of this Section 3.4 that are set forth below: 
 (a) Co-Sale
Notice. As soon as practicable following the expiration of the Investor Option Period, and in no event later than five (5) days thereafter, the Transferring Stockholder shall provide notice to each of the Investors (the “Co-Sale
Notice”) of its right to participate in the Transaction Offer on a pro rata basis (according to the allocation prescribed by Section 3.4(c)) with the Transferring Stockholder (the “Co-Sale Option”). To the
extent one or more Investors exercise their Co-Sale Option in accordance with this Section 3.4, the number of Shares that the Transferring Stockholder may Transfer pursuant to the Transaction Offer shall be correspondingly reduced. 

(b) Investor Acceptance. Each of the Investors shall have the right to exercise its Co-Sale Option by giving written notice (the
“Co-Sale Acceptance Notice”) to the Transferring Stockholder within ten (10) days after receipt by such Investor of the Co-Sale Notice (the “Co-Sale Election Period”). Each Co-Sale Acceptance Notice shall set
forth the maximum number of Shares subject thereto that the Investor wishes to sell, including the number of Shares it would sell if one or more other Investors do not elect to participate in the sale on the terms and conditions stated in the Offer
Notice. Any Investor holding Preferred Stock shall be permitted to sell to a Buyer in connection with any exercise of the Co-Sale Option, at its option, (i) shares of Common Stock acquired upon conversion of such Preferred Stock or
(ii) shares of Preferred Stock; provided, that in the case of (A) the sale of Convertible Preferred Stock, such Buyer shall pay for each such share the greater of (1) the full liquidation preference of each such share of
Convertible Preferred Stock and (2) the sum of the liquidation preference of each share of Redeemable Preferred Stock issuable upon conversion of such share of Convertible Preferred Stock and the relevant price per share of the underlying
shares of Common Stock and (B) the sale of Redeemable Preferred Stock, the full liquidation preference of each such share of Redeemable Preferred Stock. 
 (c) Allocation of Shares. Each Investor shall have the right to sell pursuant to the Transaction Offer that portion of its Shares that is equal to or less than the product obtained by multiplying (i) the
total number of Shares available for sale to the Buyer subject to the Transaction Offer by (ii) a fraction, the numerator of which is the total number of Shares owned by such Investor and the denominator of which is the total
number of Shares held by all Investors and the Transferring Stockholder, in each case, as of the date of the Offer Notice, subject to increase as hereinafter provided. If any Investor does not elect to sell the full amount of such Shares that such
Investor is entitled to sell pursuant to this Section 3.4, then any other Investors that have elected to sell Shares shall have the right to sell, on a pro rata basis (based on the number of Shares held by each such Investor) with any
other Investors and up to the maximum number of Shares stated in each such Investor’s Co-Sale Acceptance Notice, any Shares not elected to be sold by such Investor. 
  

 8 

 (d) Co-Sale Closing. Within ten (10) calendar days after the end of the Co-Sale Election
Period, the Transferring Stockholder shall promptly notify each participating Investor of the number of Shares held by such Investor that will be included in the sale and the date on which the Transaction Offer will be consummated, which shall be no
later than the date that is the later of (i) sixty (60) calendar days after the end of the Co-Sale Election Period and (ii) the date of the satisfaction of any governmental approval or filing requirements relating to such sale. Each
participating Investor may effect its participation in any Transaction Offer hereunder by delivering to the Buyer, or to the Transferring Stockholder for delivery to the Buyer, one or more instruments or certificates, properly endorsed for transfer,
representing the Shares such Investor elects to sell pursuant thereto. At the time of consummation of the Transaction Offer, the Transferring Stockholder shall cause the Buyer to remit directly to each participating Investor that portion of the sale
proceeds to which the participating Investor is entitled by reason of its participation in the Transaction Offer. No Shares may be purchased by the Buyer from the Transferring Stockholder unless the Buyer simultaneously purchases from the
participating Investors all of the Shares that they have elected to sell pursuant to this Section 3.4. 
 (e) Sale to Third
Party. Any Shares held by a Transferring Stockholder that are the subject of a Transaction Offer and that the Transferring Stockholder desires to Transfer to a Buyer in compliance with this Section 3.4, may be sold to such Buyer only during
the period specified in Section 3.4(d) and only on terms no more favorable to the Transferring Stockholder than those contained in the Offer Notice. Promptly after such Transfer, the Transferring Stockholder shall notify the Company and the
Investors of the consummation thereof and shall furnish such evidence of the completion and time of completion of the Transfer and of the terms thereof. Prior to the effectiveness of any Transfer to a Buyer hereunder, such Buyer shall have entered
into a Joinder Agreement, and such Buyer shall have all the rights and obligations hereunder as if such Buyer were a Management Stockholder or D.B. Zwirn, as applicable. In the event that the Transaction Offer is not consummated within the period
required by this Section 3.4 or the Buyer fails timely to remit to each participating Investor its respective portion of the sale proceeds, the Transaction Offer shall be deemed to lapse, and any Transfer of Shares arising out of or resulting
from such Transaction Offer shall be in violation of the provisions of this Agreement unless the Transferring Stockholder sends a new Offer Notice with respect to such Offered Shares and once again complies with the provisions of Section 3.3
and Section 3.4 with respect to such Transaction Offer. 
 3.5. Co-Sale Option of Management Stockholders. If any one or
more of the Investors entertains a Transaction Offer from a Buyer that is not an Affiliate of such Investor to purchase all or any portion of the Shares held by such Investor, such Investor (each, a “Transferring Investor”) may sell
such Shares to the Buyer on the terms and conditions of the Transaction Offer, subject to the provisions of this Section 3.5 that are set forth below: 
 (a) Co-Sale Notice. The Transferring Investor shall provide notice to each Management Stockholder and other Investor (the “Stockholder Co-Sale Notice”) of its right to participate in the
Transaction Offer on a pro rata basis (according to the allocation prescribed by 

  

 9 

 
Section 3.5(c)) with the Transferring Investor (the “Stockholder Co-Sale Option”). If one or more Management Stockholders or other
Investors (each, a “Participating Stockholder”) exercise their Stockholder Co-Sale Option in accordance with this Section 3.5, the number of Shares that the Transferring Investor may Transfer in the Transaction Offer shall be
correspondingly reduced. The Stockholder Co-Sale Notice shall be accompanied by a true copy of the Transaction Offer (which shall identify the Buyer and all relevant information in connection therewith). 
 (b) Acceptance. Each Management Stockholder and such other Investor shall have the right to exercise its Stockholder Co-Sale Option by giving
written notice (the “Stockholder Co-Sale Acceptance Notice”) to the Transferring Investor within ten (10) days after receipt by such Management Stockholder or other Investor of the Management Stockholder Co-Sale Notice (the
“Stockholder Co-Sale Election Period”). Each Stockholder Co-Sale Acceptance Notice shall indicate the maximum number of Shares subject thereto that the Participating Stockholder wishes to sell, including the number of Shares it
would sell if one or more other Management Stockholders or other Investors do not elect to participate in the sale on the terms and conditions stated in the Offer Notice. 
 (c) Allocation of Shares. Each Participating Stockholder shall have the right to sell pursuant to the Transaction Offer that portion of its Shares that is equal to or less than the product obtained by
multiplying (i) the total number of Shares available for sale to the Buyer subject to the Transaction Offer by (ii) a fraction, the numerator of which is the total number of Shares owned by such Participating Stockholder and the
denominator of which is the total number of Shares held by all Participating Stockholders and the Transferring Investor, in each case, as of the date of the Offer Notice, subject to increase as hereinafter provided. If any Participating
Stockholder does not elect to sell the full amount of such Shares that such Participating Stockholder is entitled to sell pursuant to this Section 3.5, then any Participating Stockholders that have elected to sell Shares shall have the right to
sell, on a pro rata basis (based on the number of Shares held by each such Participating Stockholder) with any other Participating Stockholders and up to the maximum number of Shares stated in each such Participating Stockholder’s
Stockholder Co-Sale Acceptance Notice, any Shares not elected to be sold by such Participating Stockholder. 
 (d) Co-Sale Closing.
Within ten (10) calendar days after the end of the Stockholder Co-Sale Election Period, the Transferring Investor shall promptly notify each Participating Stockholder of the number of Shares held by such Participating Stockholder that will be
included in the sale and the date on which the Transaction Offer will be consummated, which shall be no later than the date that is the later of (i) sixty (60) calendar days after the end of the Stockholder Co-Sale Election Period and
(ii) the date of the satisfaction of any governmental approval or filing requirements relating to such sale. Each Participating Stockholder may effect its participation in any Transaction Offer hereunder by delivering to the Buyer, or to the
Transferring Investor for delivery to the Buyer, one or more instruments or certificates, properly endorsed for transfer, representing the Shares it elects to sell pursuant thereto. At the time of consummation of the Transaction Offer, the
Transferring Investor shall cause the Buyer to remit directly to each Participating Stockholder that portion of the sale proceeds to which the Participating Stockholder is entitled by reason of its participation in the 

  

 10 

 
Transaction Offer. No Shares may be purchased by the Buyer from the Transferring Investor unless the Buyer simultaneously purchases from the Participating
Stockholders all of the Shares that they have elected to sell pursuant to this Section 3.5. 
 (e) Sale to Third Party. Any
Shares held by a Transferring Investor that are the subject of a Transaction Offer and that the Transferring Investor desires to Transfer to a Buyer in compliance with this Section 3.5, may be sold to such Buyer only during the period specified
in Section 3.5(d) and only on terms no more favorable to the Transferring Investor than those set forth in the Stockholder Co-Sale Notice. Promptly after such Transfer, the Transferring Investor shall notify the Company and the Management
Stockholders and other Investors of the consummation thereof and shall furnish such evidence of the completion and time of completion of the Transfer and of the terms thereof as may reasonably be requested. If the Transaction Offer is not
consummated within the period required by this Section 3.5 or the Buyer fails timely to remit to each Participating Stockholder its respective portion of the sale proceeds, the Transaction Offer shall be deemed to lapse, and any Transfer of
Shares arising out of or resulting from such Transaction Offer shall be in violation of the provisions of this Agreement unless the Transferring Investor sends a new Stockholder Co-Sale Notice with respect to such Shares and once again complies with
the provisions of Section 3.5 with respect to such Transaction Offer. 
 3.6. Drag Along. 
 (a) Upon a Sale Event (as defined below), each Management Stockholder and Investor shall, upon the written request of a Two-Thirds Interest (i) sell,
transfer and deliver, or cause to be sold, transferred and delivered, to the Third Party Buyer (as defined below) a pro rata portion of its Shares on the same terms applicable to the Two-Thirds Interest (with due reflection of the relative
rights and preferences of the Shares as provided in the Charter), and (ii) execute and deliver such instruments of conveyance and transfer and take such other action, including voting such Shares in favor of any Sale Event proposed by the
Two-Thirds Interest and executing any purchase agreements, merger agreements, indemnity agreements, escrow agreements or related documents, as such Two-Thirds Interest and the Third Party Buyer may reasonably require in order to carry out the terms
and provisions of this Section 3.6 (the “Drag-Along Right”). Notwithstanding the foregoing, no Management Stockholder in connection with any Sale Event shall be required to make any representations and warranties other than
(i) representations and warranties as to the title of its Shares and its power, authority and right to enter into the Sale Event without contravention of law or contract and (ii) such representations and warranties concerning the Company
as the Two-Thirds-Interest shall make; provided, however, that any liability for any breach thereof shall be borne by each Management Stockholder on a pro rata basis based upon the consideration in respect of its Shares received
by the Management Stockholder and shall not exceed the amount of such consideration received by the Management Stockholder. Further, notwithstanding the foregoing, no Management Stockholder shall be required to execute any purchase agreements,
merger agreements, indemnity agreements, escrow agreements or related documents containing terms applicable to the Management Stockholder that are different in any material respect from the terms applicable to the Two-Thirds Interest (after due
adjustment for the relative rights and preferences of the Shares as provided in the Charter). 
  

 11 

 (b) For purposes of this Section 3.6: 
 (i) a “Sale Event” shall mean a bona fide negotiated transaction with a third party in which the Two-Thirds Interest have
determined (A) to sell their Shares in a transaction that will result in a majority of the voting power of the Company immediately prior to such transaction being transferred to such third party, (B) to sell or otherwise dispose of all or
substantially all of the assets of the Company or (C) to cause the Company to merge with or into, or consolidate with, any non-Affiliate(s) of the Company; and 
 (ii) A “Third Party Buyer” shall mean the buyer or buyers in Section 3.6(b)(i)(A) or (B), and the surviving entity
in Section 3.6(b)(i)(C). 
 (c) Not less than thirty (30) days prior to the date proposed for the closing of any Sale Event, the
Two-Thirds Interest shall give notice to each of the Management Stockholders and Investor setting forth in reasonable detail the name or names of the Third Party Buyer, the terms and conditions of the Sale Event, including the purchase price, and
the proposed closing date. 
 3.7. Contemporaneous Transfers. If two or more Management Stockholders or Investors propose
concurrent Transfers that are subject to this Section III, then the relevant provisions of Section 3.3 and Section 3.4, as applicable, shall apply separately to each such proposed Transfer. 
 3.8. Effect of Prohibited Transfers. If any Transfer by any Management Stockholder or Investor is made or attempted in violation of the
provisions of this Agreement, (a) such purported Transfer shall be void ab initio, (b) the Company and the other parties hereto shall have, in addition to any other legal or equitable remedies available to them, the right to enforce the
provisions of this Agreement by actions for specific performance (to the extent permitted by law) and (c) the Company shall have the right to refuse to recognize any Transferee of such Management Stockholder or Investor for any purpose.

 3.9. Assignment of Rights. Subject to Section 7.11 hereof (and, in the case of D.B. Zwirn, Sections 3.1, 3.2, 3.3 and
3.4 hereof), each Investor shall have the right to assign its rights under this Section III to any Transferee of such Investor’s Shares, and any such Transferee shall be deemed within the definition of an “Investor” for purposes of
this Section III. 
 SECTION IV. RIGHTS TO PURCHASE 
 4.1. Right to Participate in Certain Sales of Additional Securities. The Company agrees that it will not sell or issue or agree to sell or issue: (a) any shares of capital stock of the Company,
(b) any securities convertible into or exercisable or exchangeable for shares of capital stock of the Company or (c) any options, warrants or rights to purchase shares of capital stock of the Company, unless the Company first submits a
written notice to each Management Stockholder and Investor identifying the terms of the proposed sale (including price, number or aggregate principal amount of securities and all other material terms), and offers to each 
  

 12 

 
Management Stockholder and Investor who is an “accredited investor,” as such term is defined in Rule 501 under the Securities Act (an
“Eligible Person”), the opportunity to purchase its Pro Rata Allotment (as hereinafter defined) of the securities (subject to increase for over-allotment if some Eligible Persons do not fully exercise their rights) on terms and
conditions, including price, not less favorable than those on which the Company proposes to sell such securities to third party (a “Pre-Emptive Right Notice”). The Company’s offer pursuant to this Section 4.1 shall remain
open and irrevocable for a period of twenty (20) days following receipt by the Eligible Persons of such written notice. 
 4.2.
Eligible Person Acceptance. Each of the Eligible Persons shall have the right to purchase its Pro Rata Allotment by giving written notice of such intent to participate (the “Pre-emptive Right Acceptance Notice”) to the
Company within twenty (20) days after receipt by such Eligible Person of the Pre-Emptive Right Notice (the “Pre-Emptive Right Acceptance Election Period”). Each Pre-Emptive Right Acceptance Notice shall set forth the maximum
number of Shares subject thereto that the Eligible Person wishes to buy, including the number of Shares it would buy if one or more other Eligible Persons elected not to participate in the sale on the terms and conditions stated in the Pre-Emptive
Right Notice. 
 4.3. Calculation of Pro Rata Allotment. Each Eligible Person’s “Pro Rata Allotment” of
such securities shall be based on the ratio that the number of Shares owned by such Eligible Person bears to all of the issued and outstanding Shares as of the date of such written offer. If one or more Eligible Persons elects not to purchase their
respective Pro Rata Allotment, each of the electing Eligible Persons may purchase such securities of each such non-electing Eligible Person’s allotments (taking into account the maximum amount each is wishing to purchase) on a pro rata basis,
based upon the relative holdings of Shares of each of the electing Eligible Persons in the case of over-subscription. 
 4.4. Sale to
Third Party. Any securities so offered that are not purchased by the Eligible Persons pursuant to the offer set forth in Section 4.1 above may be sold by the Company, but only on terms and conditions not more favorable to the purchaser
than those set forth in the applicable Pre-Emptive Right Notice, at any time after five (5) days but within thirty (30) days following the termination of the applicable Pre-Emptive Right Acceptance Election Period, but may not be sold to
any other Person or on terms and conditions, including price, that are more favorable to the purchaser than those set forth in such offer or after such 30-day period without renewed compliance with this Section IV. 
 4.5. Exceptions to Pre-Emptive Rights. Notwithstanding the foregoing, the rights granted to Eligible Persons under this Section IV shall be
inapplicable with respect to (i) the issuance of up to an aggregate of 790,909 shares of Common Stock (as appropriately adjusted for any stock split, combination, reorganization, recapitalization, reclassification, stock distribution, stock
dividend or similar event) issued or issuable in connection with, or upon the exercise of, options or other awards granted or to be granted to employees, officers or directors of the Company pursuant to the Equity Incentive Plan, including shares of
Common Stock issued in replacement of shares of such Common Stock repurchased or issuable upon the exercise of any options to purchase shares of such Common Stock, to the extent permitted under the Equity Incentive Plan, (ii) securities issued
as a result of any stock split, stock dividend, reclassification 

  

 13 

 
or reorganization or similar event with respect to the Shares, (iii) shares of Common Stock or Redeemable Preferred Stock issued upon conversion of, or
as a dividend on, the Convertible Preferred Stock, (iv) securities issued as consideration for the purchase of stock or assets in any acquisition or merger that is approved by a Two-Thirds Interest or (v) any other securities issued with
the approval of (A) a Two-Thirds Interest and (B) Management Stockholders holding not less than a majority of the outstanding Shares held by all Management Stockholders, calculated in accordance with Section 1.3 hereof (a
“Management Stockholder Majority”). 
 4.6. Assignment of Rights. Subject to Section 7.11 hereof, each
Eligible Person shall have the right to assign its rights under this Section IV to any permitted Transferee of such Eligible Person’s Shares, and shall further have the right to Transfer such Eligible Person’s right to accept any
particular offer under Section 4.1 hereof, and any such Transferee shall be deemed within the definition of an “Eligible Person” for purposes of this Section IV. 
 4.7. Company Repurchase. If any Management Stockholder ceases to be an employee of the Company, Monotype or any other subsidiary of the
Company for any reason other than a termination of such Management Stockholder’s employment (a) without Cause or for Good Reason (as each such term is defined in the Equity Incentive Plan and construed herein as though such Management
Stockholder were a “grantee” under such definitions) or (b) upon the retirement of such Management Stockholder at or after the age of sixty (60) pursuant to the established policies of the Company, the Company may elect, within
ninety (90) days of the date such employment ceased (an “Employment Termination Date”) and regardless of whether such Management Stockholder may remain a Director, to repurchase all of the Shares held by such Management
Stockholder at a price equal to the fair market value of such Shares as of the applicable Employment Termination Date, as determined in good faith by (i) a majority of the Board of Directors and (ii) a majority of the Directors who are
Management Stockholder Nominees (as defined below), excluding, in each case, such Management Stockholder if such Management Stockholder is a Director at the time of such determination. 
 SECTION V. ELECTION OF DIRECTORS 
 5.1. Management Stockholder Board
Representation. Each Management Stockholder and Investor agrees to vote all of its Shares having voting power (and any other Shares over which such Management Stockholder or Investor exercises voting control) and to take such other actions
as are necessary to elect and continue in office as members of the Board of Directors three (3) Persons (each, a “Management Stockholder Nominee”) nominated by a Management Stockholder Majority, which Management Stockholder
Nominees shall initially be Robert M. Givens, Douglas J. Shaw and John Seguin; provided that all Management Stockholder Nominees must be employees of the Company, Monotype or another of the Company’s wholly-owned subsidiaries;
provided further that any Management Stockholder Nominee who is not one of such initial Management Stockholder Nominees must be reasonably acceptable to a Two-Thirds Interest. 
 5.2. Removal; Vacancies. Each Management Stockholder and Investor agrees to vote all of its Shares having voting power (and any other
Shares over which such Management 

  

 14 

 
Stockholder or Investor exercises voting control) or take any other action necessary for the removal from office of any Director who was a Management
Stockholder Nominee upon the request of a Management Stockholder Majority, and for the election to the Board of Directors of a substitute Director for such Management Stockholder Nominee nominated by such Management Stockholder Majority. Each
Management Stockholder and Investor further agrees to vote all of its Shares having voting power (and any other Shares over which such Management Stockholder or Investor exercises voting control) in such manner or take any other action as shall be
necessary or appropriate to ensure that any vacancy on the Board of Directors with respect to any Management Stockholder Nominee (or substitute therefore) that has occurred for any reason shall be filled in accordance with the provisions of this
Section V. 
 SECTION VI. COVENANTS OF THE COMPANY AND MANAGEMENT STOCKHOLDERS 
 The Company covenants and agrees with each of the Investors that: 
 6.1. Financial Statements, Reports, Etc. The Company shall furnish to each Investor the following reports: 
 (a) Annual Financial Statements. Within ninety (90) days after the end of each fiscal year of the Company, a consolidated balance sheet of the Company and its subsidiaries as of the end of such fiscal year
and the related consolidated statements of income, stockholders’ equity and cash flows for the fiscal year then ended, prepared in accordance with generally accepted accounting principles and certified by a firm of independent public
accountants of recognized national standing selected by the Board of Directors of the Company; 
 (b) Quarterly Financial Statements.
Within forty-five (45) days after the end of each fiscal quarter of the Company, a consolidated balance sheet of the Company and its subsidiaries and the related consolidated statements of income, stockholders’ equity and cash flows for
the fiscal quarter then ended, unaudited but prepared in accordance with generally accepted accounting principles and certified by the chief financial officer of the Company, such consolidated balance sheet to be as of the end of such quarter and
such consolidated statements of income, stockholders’ equity and cash flows to be for such quarter and for the period from the beginning of the fiscal year to the end of such quarter, in each case with comparative statements for the prior
fiscal year; 
 (c) Monthly Financial Statements. Within twenty-five (25) days after the end of each month in each fiscal year
(other than the last month in each fiscal year), a consolidated balance sheet of the Company and its subsidiaries and the related consolidated statements of income, stockholders’ equity and cash flows for the monthly period then ended,
unaudited but prepared in accordance with generally accepted accounting principles and certified by the chief financial officer of the Company, such consolidated balance sheet to be as of the end of such month and such consolidated statements of
income, stockholders’ equity and cash flows to be for such month and for the period from the beginning of the fiscal year to the end of such month, in each case with comparative statements for the prior fiscal year; 
  

 15 

 (d) Budget. No later than thirty (30) days prior to the start of each fiscal year of the
Company, consolidated capital and operating expense budgets, cash flow projections and income and loss projections for the Company and its subsidiaries in respect of such fiscal year, all itemized in reasonable detail and prepared on a monthly
basis, and, promptly after preparation, any revisions to any of the foregoing; 
 (e) Accountant’s Letters. Promptly following
receipt by the Company, each audit response letter, accountant’s management letter and other written report submitted to the Company by its independent public accountants in connection with an annual or interim audit of the books of the Company
or any of its subsidiaries; 
 (f) Notices. Promptly after the commencement thereof, notice of all actions, suits, claims,
proceedings, investigations and inquiries that could materially and adversely affect the Company or any of its subsidiaries; and 
 (g)
Other Information. Promptly, from time to time, such other information regarding the business, prospects, financial condition, operations, property or affairs of the Company and its subsidiaries as such Investor reasonably may request.

 6.2. Inspection, Consultation and Advice. The Company shall permit, and cause each of its subsidiaries to permit, each
Investor and such persons as each such Investor may designate, at such Investor’s expense, to visit and inspect any of the properties of the Company and its subsidiaries, examine their books and take copies and extracts therefrom, discuss the
affairs, finances and accounts of the Company and its subsidiaries with their respective officers, employees and independent public accountants (and the Company hereby authorizes such accountants to discuss with each such Investor and such designees
such affairs, finances and accounts), and consult with and advise the management of the Company and its subsidiaries as to their affairs, finances and accounts, all at reasonable times and upon reasonable notice during normal business hours.
The foregoing shall be in addition to, and not in lieu of, the Investors’ rights under applicable law. 
 6.3. Key Person
Insurance. The Company shall obtain promptly after the date hereof obtain and thereafter maintain, “key person” term life insurance policies of at least $5,000,000 on the lives of each of Robert M. Givens, Douglas J. Shaw and John
Seguin that name the Company as beneficiary. 
 6.4. Directors and Officers’ Insurance; Charter and Bylaws. The Company
shall, as promptly as practicable following the date hereof, obtain and maintain directors and officers’ liability insurance coverage on terms satisfactory to a Two-Thirds Interest of at least $5,000,000 per occurrence, covering to the fullest
extent permitted by law, among other things, violations of federal or state securities laws. The Company shall use its reasonable best efforts prior to any initial public offering of the Company’s capital stock to increase its directors’
and officers’ liability insurance to at least $15,000,000 per occurrence, including coverage of claims under the Securities Act and the Exchange Act. The Company shall at all times maintain provisions in its bylaws and the Charter indemnifying
all directors against liability and absolving all directors from liability to the Company and its stockholders to the maximum extent permitted under the laws of the State of Delaware. 
  

 16 

 6.5. Reimbursement of Directors. The Company shall pay or promptly reimburse in full all of
its Directors for all of their reasonable out-of-pocket expenses incurred in attending each meeting of the Board of Directors or any committee thereof. 
 6.6. Employee Agreements. The Company shall obtain, and shall cause its subsidiaries, if any, to obtain, a Noncompetition, Confidential Information and Inventions Assignment Agreement in substantially
the form of Exhibit B attached hereto from all future officers and employees and any consultants who have or will have access to confidential information of the Company or any of its subsidiaries, upon commencement of their employment or
consulting arrangement with the Company or any of its subsidiaries. 
 6.7. Lock-Up Agreements. The Company will obtain
agreements in writing from each future holder of stock or options of the Company as a condition to any issuance of stock or grant of options, agreeing not to directly or indirectly offer, sell, contract to sell, sell any option or contract to
purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of or otherwise dispose of or transfer any shares of stock of the Company in connection with any public offering of the Company’s capital stock
without the written consent of the underwriters engaged by the Company for such offering, consistent with the provisions of Section 7.14 of this Agreement. 
 6.8. Material Adverse Change. The Company will promptly advise the Investors of any event that could have a Material Adverse Effect, and of each lawsuit or proceeding commenced or, if known by the
Company, threatened against the Company that, if adversely determined with respect to the Company could have a Material Adverse Effect. The Company will promptly advise the Investors of any recall of the Company’s products and any Proceeding
commenced or, if known by the Company, threatened that is related to the Company’s products and services. 
 6.9.
Indemnification. 
 (a) Without limitation of any other provision of this Agreement, the Company, on its own behalf and on
behalf of its successors and assigns, agrees to defend, indemnify and hold each Investor, its respective Affiliates and direct and indirect partners (including partners of partners and stockholders and members of partners), members, stockholders,
directors, officers, employees and agents and each person who controls any of them within the meaning of Section 15 of the Securities Act, or Section 20 of the Exchange Act (the “Investor Indemnified Parties”) harmless
from and against any and all damages, liabilities, losses, taxes, fines, penalties, diminution in value, reasonable costs and expenses (including, without limitation, reasonable fees of counsel, as the same are incurred, of any kind or nature
whatsoever (whether or not arising out of third-party claims and including all amounts paid in investigation, defense or settlement of the foregoing and consequential damages) (“Losses”) sustained or suffered by any such Investor
Indemnified Party, that may be based upon, relating to, arising out of, or by reason of (i) any breach of any covenant or agreement made by the 

  

 17 

 
Company in this Agreement or (ii) any third party or governmental claims relating in any way to such Investor Indemnified Party’s status as a
security holder, creditor, director, agent, representative or controlling person of the Company or otherwise relating to such Investor Indemnified Party’s involvement with the Company (including, without limitation, any and all Losses under the
Securities Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, that relate directly or indirectly to the registration, purchase, sale or ownership of any securities of the Company or to any
fiduciary obligation owed with respect thereto), including, without limitation, in connection with any third party or governmental action or claim relating to any action taken or omitted to be taken or alleged to have been taken or omitted to have
been taken by any Investor Indemnified Party as security holder, director, agent, representative or controlling person of the Company or otherwise, alleging so-called control person liability or securities law liability; provided, however,
that the Company will not be liable to any Investor Indemnified Party to the extent that such Losses arise from and are based on (A) an untrue statement or omission of material fact or alleged untrue statement or omission of material fact in a
registration statement or prospectus that is made in reliance on and in conformity with written information furnished to the Company by or on behalf of such Investor Indemnified Party or (B) conduct by such Investor Indemnified Party that, if
committed by a director of the Company, would not be indemnifiable under the terms of the Charter, the Company’s bylaws or any indemnification contracts between the Company and any of its directors. 
 (b) If the indemnification provided for in Section 6.9(a) above for any reason is held by a court of competent jurisdiction to be unavailable to an
Investor Indemnified Party in respect of any Losses referred to therein, then the Company, in lieu of indemnifying such Investor Indemnified Party thereunder, shall contribute to the amount paid or payable by such Investor Indemnified Party as a
result of such Losses (i) in such proportion as is appropriate to reflect the relative benefits received by the Company and the Investors, or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, then
in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company and the Investors in connection with the action or inaction that resulted in such Losses,
as well as any other relevant equitable considerations. The relative fault of the Company and the Investors shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company and the Investors and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.

 (c) Each of the Company and the Investors agrees that it would not be just or equitable if contribution pursuant to Section 6.9(b)
were determined by pro rata or per capita allocation or by any other method of allocation that does not take account of the equitable considerations referred to in Section 6.9(b). 
 (d) The Company agrees to pay or reimburse the Investors for all reasonable out-of-pocket costs and expenses, including, without limitation, the fees and
disbursements of counsel and other professionals, incurred by them in connection with any modification, waiver, consent or amendment relating to this Agreement or any other agreement between the Company and the Investors. 
  

 18 

 SECTION VII. MISCELLANEOUS PROVISIONS 
 7.1. Reliance. Each of the parties hereto agrees that each covenant and agreement made by it in this Agreement or in any certificate,
instrument or other document delivered pursuant to this Agreement is material, shall be deemed to have been relied upon by the other parties and shall remain operative and in full force and effect after the date hereof regardless of any
investigation by any other party. This Agreement shall not be construed to confer any right or benefit upon any Person other than the parties hereto and their respective successors and permitted assigns to the extent contemplated herein. 

7.2. Legend on Securities. The Company and the Management Stockholders acknowledge and agree that, in addition to any other legend on
the certificates representing Shares that may be held by them, the following legend (or one substantially similar to it) shall be typed on each certificate evidencing any of the Shares held at any time by any of the Management Stockholders:

 THE SECURITIES REPRESENTED HEREBY ARE SUBJECT TO THE PROVISIONS OF A CERTAIN STOCKHOLDERS AGREEMENT, DATED AS OF NOVEMBER     ,
2004, INCLUDING CERTAIN RESTRICTIONS ON TRANSFER SET FORTH THEREIN. A COMPLETE AND CORRECT COPY OF SUCH AGREEMENT IS AVAILABLE FOR INSPECTION AT THE PRINCIPAL OFFICE OF THE COMPANY AND WILL BE FURNISHED UPON WRITTEN REQUEST AND WITHOUT CHARGE.

 7.3. Amendment and Waiver; Actions of the Board. Any party may waive in writing any provision hereof intended for its
benefit. No failure or delay on the part of any party hereto in exercising any right, power or remedy hereunder shall operate as a waiver thereof. The remedies provided for herein are cumulative and are not exclusive of any remedies that may be
available to any party hereto at law or in equity or otherwise. This Agreement may be amended with the prior written consent of the Company, a Two-Thirds Interest and a Management Stockholder Majority. Any consent given as provided in the preceding
sentence shall be binding on all Management Stockholders. 
 7.4. Notices. All notices, requests, demands and other
communications provided for hereunder shall be in writing and mailed (by first class registered or certified mail, postage prepaid), telegraphed, sent by express overnight courier service or electronic facsimile transmission (with a copy by mail),
or delivered to the applicable party at the addresses indicated below: 
 If to the Company: 
 Monotype Imaging Holdings Corp. 
 200
Ballardvale Street 
 Wilmington, MA 01887 
 Attn:                                  

Telecopy No.:
                                 
  

 19 

 With a copy to: 
 TA Associates, Inc. 
 High Street Tower, Suite 2500 
 125 High Street 
 Boston, MA 02110 

Attn: A. Bruce Johnston 
           Jonathan W. Meeks 
 Telecopy No.: (617) 574-6728 
 If to the Investors: 
 TA Associates, Inc.

 High Street Tower, Suite 2500 
 125 High Street 
 Boston, MA 02110 
 Attn: A. Bruce Johnston 
           Jonathan W. Meeks

 Telecopy No.: (617) 574-6728 
 And: 
 D.B. Zwirn Special Opportunities Fund, L.P. 
 745 Fifth Avenue, 18th Floor 
 New York, NY 10151 
 Attention: Vasan Kesavan,
Esq. 
 Telecopy No.: (646) 746-8669 
 With a copy to: 
 Goodwin Procter LLP 
 Exchange Place 
 53 State Street 

Boston, MA 02109 
 Attn: Jeffrey C. Hadden,
P.C. 
 Telecopy No.: (617) 523-1231 
 If to a Management Stockholder: 
 At such Management Stockholder’s address as then set forth in the
books and records of the Company; 
  

 20 

 
or, as to each of the foregoing, at such other address as shall be designated by applicable party in a written notice to other parties complying as to
delivery with the terms of this Section 7.4. All such notices, requests, demands and other communications shall, when mailed, telegraphed or sent, respectively, be effective (i) two days after being deposited in the mails or (ii) one
day after being delivered to the telegraph company, deposited with the express overnight courier service or sent by electronic facsimile transmission, respectively, addressed as aforesaid. 
 7.5. Headings. The section headings used or contained in this Agreement are for convenience of reference only and shall not affect the
construction of this Agreement. The parties have participated jointly in the negotiation and drafting of this Agreement and the other agreements, documents and instruments executed and delivered in connection herewith with counsel sophisticated in
investment transactions. If an ambiguity or question of intent or interpretation arises, this Agreement and the agreements, documents and instruments executed and delivered in connection herewith shall be construed as if drafted jointly by the
parties and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the agreements, documents or instruments executed and delivered in connection
herewith. 
 7.6. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. 
 7.7. Remedies; Severability. 

(a) It is specifically understood and agreed that any breach of the provisions of this Agreement by any Person subject hereto will result in
irreparable injury to the other parties hereto, that the remedy at law alone will be an inadequate remedy for such breach, and that, in addition to any other legal or equitable remedies that they may have, such other parties may enforce their
respective rights by actions for specific performance (to the extent permitted by law) and the Company may refuse to recognize any unauthorized Transferee as one of its stockholders for any purpose, including, without limitation, for purposes of
dividend and voting rights, until the relevant party or parties have complied with all applicable provisions of this Agreement. 
 (b) If one
or more of the provisions contained herein, or the application thereof in any circumstances, is held invalid, illegal or unenforceable in any respect for any reason by a court of competent jurisdiction, the validity, legality and enforceability of
any such provision in every other respect and of the remaining provisions contained herein shall not be in any way impaired thereby, it being intended that all of the rights and privileges of the parties hereto shall be enforceable to the fullest
extent permitted by law. 
 7.8. Entire Agreement. This Agreement constitutes the entire understanding among the parties hereto
and supersedes any prior agreement, written or oral, with respect to the subject matter hereof. 
  

 21 

 7.9. Adjustments. All references to share prices and amounts herein shall be equitably
adjusted to reflect stock splits, stock dividends, recapitalizations and similar changes affecting the capital stock of the Company. 
 7.10.
Law Governing. This Agreement shall be construed and enforced in accordance with and governed by the laws of the Commonwealth of Massachusetts (without giving effect to principles of conflicts of law). 
 7.11. Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the respective successors and permitted
assigns of the parties hereto as contemplated herein, and any successor to the Company by way of merger or otherwise shall specifically agree to be bound by the terms hereof as a condition of such succession. The rights of the Investors hereunder
shall be binding upon and inure to the benefit of their Transferees of their Shares as contemplated herein; provided, however, that in no event may any of the rights of D.B. Zwirn under Section VI be Transferred to any Transferee of any of
its Shares (other than to a Transferee pursuant to a Transfer permitted pursuant to Section 3.2(d) hereof). Except as expressly provided herein, no Management Stockholder may assign any of its rights or delegate any of its obligations hereunder
without the prior written consent of the Company and a Two-Thirds Interest, and without such prior written consent any attempted assignment or delegation shall be null and void. 
 7.12. Dispute Resolution. 
 (a)
All disputes, claims, or controversies arising out of or relating to this Agreement, or any other agreement executed and delivered pursuant to this Agreement, or the negotiation, validity or performance hereof and thereof or the transactions
contemplated hereby and thereby, that are not resolved by mutual agreement shall be resolved solely and exclusively by binding arbitration to be conducted before J.A.M.S./Endispute, Inc. in Boston, Massachusetts before a single arbitrator (the
“Arbitrator”). 
 (b) The parties covenant and agree that the arbitration shall commence within ninety (90) days of the
date on which a written demand for arbitration is filed by any party hereto. In connection with the arbitration proceeding, the arbitrator shall have the power to order the production of documents by each party and any third-party witnesses. In
addition, each party may take up to three depositions as of right, and the arbitrator may in his or her discretion allow additional depositions upon good cause shown by the moving party. However, the arbitrator shall not have the power to order the
answering of interrogatories or the response to requests for admission. In connection with any arbitration, each party shall provide to the other, no later than seven (7) business days before the date of the arbitration, the identity of all
persons that may testify at the arbitration, a copy of all documents that may be introduced at the arbitration or considered or used by a party’s witness or expert. The Arbitrator’s decision and award shall be made and delivered within six
(6) months of the selection of the Arbitrator. The Arbitrator’s decision shall set forth a reasoned basis for any award of damages or finding of liability. The Arbitrator shall not have power to award damages in excess of actual
compensatory damages and shall not multiply actual damages or award punitive damages or any other damages that are specifically excluded under this Agreement, and each party hereby irrevocably waives any claim to such damages. 
  

 22 

 (c) The parties covenant and agree that they will participate in the arbitration in good faith and that
they will, except as provided below, (i) bear their own attorney’s fees, costs and expenses in connection with the arbitration and (ii) share equally in the fees and expenses charged by the Arbitrator. The Arbitrator may in his or her
discretion assess costs and expenses (including the reasonable legal fees and expenses of the prevailing party) against any party to a proceeding. Any party unsuccessfully refusing to comply with an order of the Arbitrator’s shall be liable for
costs and expenses, including attorneys’ fees, incurred by the other party in enforcing the award. This Section 7.12 applies equally to requests for temporary, preliminary or permanent injunctive relief, except that in the case of
temporary or preliminary injunctive relief any party may proceed in court without prior arbitration for the limited purpose of avoiding immediate and irreparable harm or to enforce its rights under any non-competition covenants. 
 (d) Each of the parties hereto irrevocably and unconditionally consents to the exclusive jurisdiction of J.A.M.S./Endispute, Inc. to resolve all
disputes, claims or controversies arising out of or relating to this Agreement or any other agreement executed and delivered pursuant to this Agreement or the negotiation, validity or performance hereof and thereof or the transactions contemplated
hereby and thereby and further consents to the jurisdiction of the courts of the Commonwealth of Massachusetts for the purposes of enforcing the arbitration provisions of Section 7.12 of this Agreement. Each party further irrevocably waives any
objection to proceeding before the Arbitrator based upon lack of personal jurisdiction or to the laying of venue and further irrevocably and unconditionally waives and agrees not to make a claim in any court that arbitration before the Arbitrator
has been brought in an inconvenient forum. Each of the parties hereto hereby consents to service of process by registered mail at the address to which notices are to be given. Each of the parties hereto agrees that its or his submission to
jurisdiction and its or his consent to service of process by mail is made for the express benefit of the other parties hereto. 
 7.13.
Termination. Sections III, IV, V and VI shall terminate upon a Qualified Public Offering; provided, that the covenants set forth in Section 6.4 and Section 6.5 hereof shall continue for so long as any person nominated
by a Two-Thirds Interest for election to the Board of Directors is a member of the Board of Directors, and the covenants set forth in Section 6.9 hereof shall continue for so long as any Investor holds any Shares or until the expiration of the
applicable statute of limitations, if later. 
 7.14. Stockholder Lock-Up. Each Management Stockholder and D.B. Zwirn
hereby agrees, if so requested by the Company and an underwriter retained by the Company in connection with any public offering of securities of the Company and if each stockholder of the Company will be similarly bound, not to directly or
indirectly offer, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant for the sale of or otherwise dispose of or transfer any Shares or other securities of the
Company held by it for (a) one hundred eighty (180) days following the consummation of the Company’s initial public offering of Common Stock or (b) ninety (90) days following the consummation of any other public offering of
Common Stock, as such underwriter shall specify reasonably and in good faith. 
  

 23 

 7.15. Confidentiality. Each Investor and Management Stockholder agrees that it shall hold
in confidence, and shall cause its Affiliates and its and their Permitted Transferees to hold in confidence, unless compelled to disclose by judicial or administrative process or by other requirements of applicable law, all information and documents
relating to the Company or any of its Affiliates or any of the other parties to this Agreement provided to or acquired by such Investor or Management Stockholder pursuant to its rights under this Agreement or otherwise in connection with its
investment in the Company, except to the extent that such information or documents can be shown to have been (a) previously known on a non-confidential basis by such Investor or Management Stockholder or (b) in the public domain through no
fault of such Investor or Management Stockholder. 
 [SIGNATURE PAGES FOLLOW] 
  

 24 

 IN WITNESS WHEREOF, the parties hereto have caused this Stockholders Agreement to be duly executed as of
the date first set forth above. 
 THE COMPANY: 
  

			
	MONOTYPE IMAGING HOLDINGS CORP.
		
	By:	 	 /s/ A. BRUCE JOHNSTON

	Name:	 	A. Bruce Johnston
	Title:	 	Vice President

 Stockholders Agreement 

 INVESTORS: 
  

					
	TA IX L.P.
	By: TA Associates IX LLC, its General Partner
	By: TA Associates, Inc., its Manager
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA/ATLANTIC AND PACIFIC IV L.P.
	By: TA Associates AP IV L.P., its General Partner
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA STRATEGIC PARTNERS FUND A L.P.
	By: TA Associates SPF L.P., its General Partner
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA STRATEGIC PARTNERS FUND B L.P.
	By: TA Associates SPF L.P., its General Partner
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director

 Stockholders Agreement 

					
	TA INVESTORS II, L.P.
	By: TA Associates, Inc., its General Partner
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director
	
	TA SUBORDINATED DEBT FUND, L.P.
	By: TA Associates SDF LLC, its General Partner
	By: TA Associates, Inc., its Manager
			
		 	By:	 	 *

		 	Name:	 	A. Bruce Johnston
		 	Title:	 	Managing Director

  

			
	* By:	 	 /s/ A. BRUCE JOHNSTON

	Name:	 	A. Bruce Johnston
	Title:	 	Managing Director

  

					
	D.B. ZWIRN SPECIAL
	OPPORTUNITIES FUND, L.P.
	By: D.B. Zwirn Partners, LLC, its General Partner
	By: Zwirn Holdings, LLC, its Managing Member
			
		 	By:	 	 /s/ DANIEL B. ZWIRN

		 	Name:	 	Daniel B. Zwirn
		 	Title:	 	Managing Partner

 Stockholders Agreement 

 EXHIBIT A 
 Form of Joinder Agreement 
 The undersigned hereby agrees, effective as of the date hereof, to become
a party to that certain Stockholders Agreement (the “Agreement”) dated as of November 5, 2004, by and among Monotype Imaging Holdings Corp. (the “Company”) and the parties named therein and for all purposes of the Agreement,
the undersigned shall be included within the term [“Management Stockholder”/”Investor”] (as defined in the Agreement). The undersigned further confirms that the representations and warranties contained in
Section II of the Agreement are true and correct as to the undersigned as of the date hereof. The address and facsimile number to which notices may be sent to the undersigned is as follows: 
 Facsimile No.
                                 
  

	
	  
 [NAME OF
UNDERSIGNED]

  

 SCHEDULE A 
 Investors: 
 TA IX L.P. 
 TA/Atlantic and Pacific
IV L.P. 
 TA Strategic Partners Fund A L.P. 
 TA Strategic
Partners Fund B L.P. 
 TA Investors II, L.P. 
 TA Subordinated
Debt Fund, L.P. 
 D.B. Zwirn Special Opportunities Fund, L.P.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00116-of-00352.parquet"}]]